Skip Navigation


Carcinogenesis Advance Access originally published online on January 8, 2009
Carcinogenesis 2009 30(4):636-644; doi:10.1093/carcin/bgp009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/4/636    most recent
bgp009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lu, J.
Right arrow Articles by Wen, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, J.
Right arrow Articles by Wen, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Grape seed extract inhibits VEGF expression via reducing HIF-1{alpha} protein expression

Jianming Lu, Keqiang Zhang, Shiuan Chen1 and Wei Wen*

Department of Molecular Medicine
1 Division of Tumor Cell Biology, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA

* To whom correspondence should be addressed. Tel: +1 626 256 4673 ext. 65275; Fax: +1 626 301 8310; Email: wwen{at}coh.org

Grape seed extract (GSE) is a widely consumed dietary supplement that has antitumor activity. Here, we have investigated the inhibitory effect of GSE on the expression of vascular endothelial growth factor (VEGF) and the mechanism underlying this action. We found that GSE inhibited VEGF messenger RNA (mRNA) and protein expression in U251 human glioma cells and MDA-MB-231 human breast cancer cells. GSE inhibited transcriptional activation of the VEGF gene through reducing protein but not mRNA expression of hypoxia-inducible factor (HIF) 1{alpha}. The inhibitory effect of GSE on HIF-1{alpha} expression was mainly through inhibiting HIF-1{alpha} protein synthesis rather than promoting protein degradation. Consistent with this result, GSE-suppressed phosphorylation of several important components involved in HIF-1{alpha} protein synthesis, such as Akt, S6 kinase and S6 protein. Furthermore, in the MDA-MB-231 tumor, we found that GSE treatment inhibited the expression of VEGF and HIF-1{alpha} and the phosphorylation of S6 kinase without altering the subcellular localization of HIF-1{alpha}, correlating with reduced vessel density and tumor size. Depletion of polyphenol with polyvinylpyrrolidone abolished the inhibitory activity of GSE, suggesting a water-soluble fraction of polyphenol in GSE is responsible for the inhibitory activity. Taken together, our results indicate that GSE inhibits VEGF expression by reducing HIF-1{alpha} protein synthesis through blocking Akt activation. This finding provides new insight into the mechanisms of anticancer activity of GSE and reveals a novel molecular mechanism underlying the antiangiogenic action of GSE.

Abbreviations: CHX, cycloheximide; DFX, deferoxamine mesylate; GSE, grape seed extract; HIF, hypoxia-inducible factor; Luc, luciferase; MAPK, mitogen-activated protein kinase; mRNA, messenger RNA; PCR, polymerase chain reaction; PI3K, phosphoinositide-3-kinase; PVPP, polyvinylpyrrolidone; RT-PCR, real-time PCR; siRNA, small interfering RNA; VEGF, vascular endothelial growth factor

Received August 5, 2008; revised November 29, 2008; accepted December 29, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.